Abstract:Approximately 100,000 primary and metastatic brain tumor patients/year in the US survive long enough (>6 months) to experience radiation-induced brain injury. Prior to 1970, the human brain was thought to be highly radioresistant; the acute CNS syndrome occurs after single doses >30 Gy; white matter necrosis occurs at fractionated doses >60 Gy. Although white matter necrosis is uncommon with modern techniques, functional deficits, including progressive impairments in memory, attention, and executive function have become important, because they have profound effects on quality of life. Preclinical studies have provided valuable insights into the pathogenesis of radiation-induced cognitive impairment. Given its central role in memory and neurogenesis, the majority of these studies have focused on the hippocampus. Irradiating pediatric and young adult rodent brains leads to several hippocampal changes including neuroinflammation and a marked reduction in neurogenesis. These data have been interpreted to suggest that shielding the hippocampus will prevent clinical radiation-induced cognitive impairment. However, this interpretation may be overly simplistic. Studies using older rodents, that more closely match the adult human brain tumor population, indicate that, unlike pediatric and young adult rats, older rats fail to show a radiation-induced decrease in neurogenesis or a loss of mature neurons. Nevertheless, older rats still exhibit cognitive impairment. This occurs in the absence of demyelination and/or white matter necrosis similar to what is observed clinically, suggesting that more subtle molecular, cellular and/or microanatomic modifications are involved in this radiation-induced brain injury. Given that radiation-induced cognitive impairment likely reflects damage to both hippocampal- and non-hippocampal-dependent domains, there is a critical need to investigate the microanatomic and functional effects of radiation in various brain regions as well as their integration at clinically relevant doses and schedules. Recently developed techniques in neuroscience and neuroimaging provide not only an opportunity to accomplish this, but they also offer the opportunity to identify new biomarkers and new targets for interventions to prevent or ameliorate these late effects.

How cancer harms the developing brain: long term outcomes in pediatric cancer survivors

Neurocognitive Interventions for Children and Adolescents Surviving Cancer

Long-term Survivors of Childhood Brain Tumors: Impact on General Health and Quality of Life

Late neurocognitive sequelae in survivors of brain tumours in childhood

Neuropsychological sequelae of childhood brain tumors: A review

Developmental perspectives on optimizing educational and vocational outcomes in child and adult survivors of cancer

Neuropsychological rehabilitation for survivors of childhood and adolescent brain tumors: a view of the past and a vision for a promising future

Pediatric brain tumors: the era of molecular diagnostics, targeted and immune-based therapeutics, and a focus on long term neurologic sequelae

CNSC-01. UNDERSTANDING PEDIATRIC BRAIN TUMOR CHEMOTHERAPY INDUCED LONG-TERM DEFICITS IN HIGH-ORDER NEUROCOGNITIVE AND SENSORIMOTOR FUNCTION

Childhood Brain Tumor Survivors—A Vulnerable Group That May Be Inadvertently Overlooked

Cnsc-04. Understanding Pediatric Brain Tumor Chemotherapy Induced Long-Term Deficits In High-Order Neurocognitive And Sensorimotor Function

The impact of neuroimaging advancement on neurocognitive evaluation in pediatric brain tumor survivors: A review

Neuropsychological Late Effects and Quality-of-Life Outcomes in Pediatric Brain Tumor Survivors: Role of Pediatric Neurologists in Monitoring and Management

Radiation-induced brain injury: A review

Psychosocial and Neurocognitive Outcomes in Adult Survivors of Adolescent and Early Young Adult Cancer: A Report From the Childhood Cancer Survivor Study

A systematic review of interventions for neurocognitive dysfunctions in patients and survivors of a pediatric brain tumor

Short and Long-Term Toxicity in Pediatric Cancer Treatment: Central Nervous System Damage

Precision Medicine in Pediatric Neurooncology: A Review

Social affective outcomes and brain injury in children and adolescents treated for brain tumours

How I Treat: long-term survivors of childhood acute leukemia

Neurologic Complications in Adult Cancer Survivorship